| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Bacteriology and Immunology, Harvard Medical School, Boston, Massachusetts
Highly susceptible, newborn F1 hybrids of AK/Jax x C3Hf/Bi/Gs/L3 strain mice, referred to as AK/Z, received Gross Passage A virus i.p., and the leukemogenic process was altered by 2 forms of intervention affecting the target organ, the thymus.
Death from leukemia was delayed but not prevented by monthly courses of cortisone, 1 mg s.c. daily for 3 days. The delay was inversely proportional to the age at which the hormone injections were begun. Delay was possible even when these were begun during the period in which the leukemogenic process was already completed or nearly complete, as judged by previous studies of pathogenesis.
In mice thymectomized at 5 weeks of age, the interrupted leukemogenic process could not be reinitiated by i.p. injections of thymic extract from 12 normal mice every 67 days, continued for 5 months. Injections of normal mouse thymus in normal newborn AK/Z mice resulted in early lymphocytic lymphoma in 4 of 20 mice.
1 Presented before the American Association for Cancer Research at the annual meeting in Toronto, May 23, 1963.
2 This research was supported by a grant from the USPHS, National Cancer Institute, No. CA-04965.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |